扫描下面的二维码:

二维码

"病毒性肝炎"标签列表

TREATMENT OF CHRONIC HEPATITIS C2008-04-30

The States of Hepatities advocacy in Europe2008-04-30

TENOFOVIR DISOPROXIL FUMARATE (TDF) FOR THE TREATMENT2008-04-30

RIBAVIRIN CONCENTRATION AT WEEK FOUR IS AN INDEPENDEND PREDICTOR2008-04-30

RAPID VIROLOGICAL RESPONSE IS A MORE IMPORTANT PREDICTOR2008-04-30

REGRESSION OF HEPATITIS C-RELATED CIRRHOSIS AND LONG-TERM SURVIVAL2008-04-30

INTERFERON REGULATED GENE EXPRESSION IN THE LIVER DETERMINES RESPONSE TO TREATMENT IN CHRONIC HEPATI2008-04-30

FACTORS PREDICTIVE OF RELAPSE IN GENOTYPE 2 AND 3 PTS TREATED FOR 12 WEEKS WITH PEGIFN ALFA 2B AND W2008-04-30

Metabolic syndrome in the treatment of chronic hepatitis C2008-04-30

PD1表达的纵向分析:慢性乙肝抗病毒治疗中HBeAg血清转换的影响2008-04-29

慢性乙肝感染者中病毒体的半衰期与病毒载量具有强相关性2008-04-29

第二代核苷抑制剂--IDX102和IDX184在HCV感染的黑猩猩中具有有效的抗病毒活性2008-04-29

R7128连续用药28天(500mg bid)后的暂时结果2008-04-29

醋酸艾塞那肽-4对细胞的保护作用,一种胆管上皮GLP-1受体激动剂2008-04-29

《国际肝病》采访F.Marra教授2008-04-29

活化的肝脏NKT细胞通过细胞因子-趋化因子的级联反应募集表达CXCR3的调节性T细胞2008-04-29

Improving Treatment Response in Chronic HCV2008-04-29

Bile acids enhance genotype 1 HCV replication2008-04-29

Improving Health-Related Quality of Life in CHC Patients: Can We Improve the Status Quo?2008-04-29

In Vitro Activity and Pharmacologic Properties of Two Novel Series of HCV Protease Inhibitors2008-04-29

领域标签 >>



设为首页 | 加入收藏 | 网站地图 | 订阅杂志 | 关于我们 | 版权声明 | 联系方式|招贤纳士
国际肝病  版权所有  京ICP备15060708号   (京)-非经营性-2016-0001京公网安备 11010502033341号 2004-2020  www.ihepa.com  ALL Rights  Reserved

增值电信业务经营许可证:京B2-20212326

网站统计